Plant Comparison

Lingzhi vs Milk Thistle

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant

Second plant

Plant ALingzhiGanoderma lingzhiGanodermataceaeFull monograph →

Plant BMilk ThistleSilybum marianumAsteraceaeFull monograph →

At a glance

Lingzhi and Milk Thistle: they share 6 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cancer (anticancer research), …); 4 pharmacological actions in common.

LingzhiMilk Thistle

Constituents22

Pharmacological actions76

Indicated uses1110

Safety notes22

Cited sources2117

Indicated uses

Only Lingzhi

Cardiovascular / heart healthCold & fluImmune supportInfection (general)Insomnia / sleeplessness

Shared (6)

Arthritis / joint painBlood sugar / diabetes supportCancer (anticancer research)Inflammation (general)Metabolic supportSkin irritation

Only Milk Thistle

BloatingDetox / cleansingIndigestionLiver support

Pharmacological actions

Only Lingzhi

AntiviralImmunomodulator / immune supportSedative / sleep support

Shared (4)

Anti-inflammatoryAnticancer (preclinical)Antidiabetic (blood-sugar lowering)Antioxidant

Only Milk Thistle

Digestive aidHepatoprotective (liver support)

Evidence face-off — shared uses

Condition	Lingzhi	Milk Thistle	Verdict
Arthritis / joint pain	1/10	5/10	Stronger for Milk Thistle
Blood sugar / diabetes support	1/10	7/10	Stronger for Milk Thistle
Cancer (anticancer research)	8/10	7/10	Comparable evidence
Inflammation (general)	1/10	5/10	Stronger for Milk Thistle
Metabolic support	1/10	7/10	Stronger for Milk Thistle
Skin irritation	1/10	5/10	Stronger for Milk Thistle

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Beta-glucan polysaccharides^{[1, 4]}

Principal immunomodulatory constituents, the main focus of anticancer-adjunct and immune research.

Polysaccharides

Triterpenes (ganoderic acids)^[1]

Bitter triterpenes associated with anti-inflammatory, hepatoprotective and adaptogenic activity.

Triterpene saponinsTerpenes / terpenoids

Silymarin (a flavonolignan complex)^{[12, 13]}

The active complex; silybin (silibinin) is the most active component, with silydianin and silychristin.

Silymarin (silybin)

Flavonoids^[13]

Additional antioxidant constituents of the seed.

Flavonoids

Pharmacological Actions

Anti-inflammatory^{[2, 6, 14, 15, 16]}

Anticancer (preclinical)^{[4, 9, 10, 13, 14, 15, 16]}

Antidiabetic (blood-sugar lowering)^{[5, 9, 14, 15, 16]}

Antioxidant^{[5, 7, 14, 15, 16]}

Antiviral^{[6, 14, 15, 16]}

Immunomodulator / immune support^{[4, 5, 8, 10, 12, 14, 15, 16]}

Sedative / sleep support^{[14, 15, 16]}

Anti-inflammatory^{[11, 12, 13]}

Anti-inflammatory and antioxidant

Anticancer (preclinical)^{[5, 13]}

Antidiabetic (blood-sugar lowering)^{[10, 14]}

Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c

Antioxidant^{[2, 6, 12, 13]}

Anti-inflammatory and antioxidant; Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic)

Digestive aid^[12]

Digestive support / mild dyspepsia (traditional)

Hepatoprotective (liver support)^{[1, 2, 3, 4, 6, 7, 9, 12, 13, 15]}

Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD); Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)

Traditional & Indicated Uses

Arthritis / joint pain^{[14, 15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Arthritis / joint pain

Blood sugar / diabetes support^{[14, 15, 16]}Traditional · 1/10

inferred from antidiabetic action

Evidence: 1

Label: Blood sugar / diabetes support

Cancer (anticancer research)^{[1, 4, 10, 15]}Good · 8/10

inferred from anticancer action

Evidence: 8

Label: Cancer (anticancer research)

Cardiovascular / heart health^{[14, 15, 16]}Traditional · 1/10

Evidence: 1

Label: Cardiovascular / heart health

Cold & flu^{[14, 15, 16]}Traditional · 1/10

inferred from antiviral action

Evidence: 1

Label: Cold & flu

Immune support^{[14, 15, 16]}Traditional · 1/10

Evidence: 1

Label: Immune support

Infection (general)^{[14, 15, 16]}Traditional · 1/10

inferred from antiviral action

Evidence: 1

Label: Infection (general)

Inflammation (general)^{[14, 15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Inflammation (general)

Insomnia / sleeplessness^{[14, 15, 16]}Traditional · 1/10

inferred from sedative action

Evidence: 1

Label: Insomnia / sleeplessness

Metabolic support^{[14, 15, 16]}Traditional · 1/10

inferred from antidiabetic action

Evidence: 1

Label: Metabolic support

Skin irritation^{[14, 15, 16]}Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1

Label: Skin irritation

Arthritis / joint pain^{[12, 13]}Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5

Label: Arthritis / joint pain

Bloating^[12]Moderate · 5/10

inferred from digestive action

Evidence: 5

Label: Bloating

Blood sugar / diabetes support^[14]Good · 7/10

Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c

Evidence: 7

Label: Blood sugar / diabetes support

Cancer (anticancer research)^{[5, 13]}Good · 7/10

inferred from anticancer action

Evidence: 7

Label: Cancer (anticancer research)

Detox / cleansing^[12]Moderate · 5/10

Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)

Evidence: 5

Label: Detox / cleansing

Indigestion^[12]Moderate · 5/10

Digestive support / mild dyspepsia (traditional)

Evidence: 5

Label: Indigestion

Inflammation (general)^{[12, 13]}Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5

Label: Inflammation (general)

Liver support^{[12, 13, 15]}Good · 8/10

Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD)

Evidence: 8

Label: Liver support

Metabolic support^[14]Good · 7/10

inferred from antidiabetic action

Evidence: 7

Label: Metabolic support

Skin irritation^{[12, 13]}Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5

Label: Skin irritation

Safety, Cautions & Contraindications

Safety note^{[14, 15, 16]}Caution

Generally well tolerated at standard doses. May cause mild digestive upset, dry mouth, or dizziness in some individuals. May enhance the effects of anticoagulant and antihypertensive medications. Avoid during pregnancy and breastfeeding. Extended use beyond 6 months is not well studied in humans.

Safety note^{[14, 15, 16, 17]}Caution

Duke (2002) rates reishi (Ganoderma lucidum) as + and notes immunostimulant, hepatoprotective, antioxidant, antitumor, and hypoglycemic activities at the experimental level (score 1). It is a key adaptogen in traditional Chinese medicine, valued for its polysaccharide (beta-glucan) content. Duke notes antiviral (score 1) and anti-aggregant activities. No strong clinical trials existed at time of publication, but lentinan and polysaccharide fractions from related species show immunomodulatory potential. Duke suggests caution in bleeding disorders due to anti-aggregant activity (Duke, 2002).

Safety note^[12]Info

Very well tolerated, even at high doses; the main effects are mild gastrointestinal upset (nausea, loose stools). As a member of the daisy family (Asteraceae), it can cause allergic reactions in sensitive people.

Safety note^[12]Caution

Has a low potential for drug interactions (little effect on liver CYP enzymes), but use caution with medicines that have a narrow therapeutic window. Human pregnancy data are limited, so use cautiously.

External Ids

Gbif: 7690471

Wikidata: Q97958947

Gbif: 3145214

Wikidata: Q193798

Botanical Description

Bracket (shelf) fungus (not a true plant) that grows on the trunks and stumps of deciduous trees. It develops a hard, kidney- or fan-shaped cap with a glossy, varnished, red-brown to mahogany crust and concentric growth rings, often on a lateral woody stalk; the pale underside is covered in fine pores that release rusty-brown spores. The mycelium spreads through the wood substrate before fruiting.^[1]

Height: Cap 5-20 cm across

Habit: Perennial wood-decay bracket fungus

Leaves: Not applicable (fungus)

Flowers: Not applicable (fungus); reproduces by spores

Stem: Hard, glossy, varnished kidney- or fan-shaped cap, often on a lateral stalk

Root: Mycelium spreading through the wood substrate

Fruit: Pale, finely pored underside releasing rusty-brown spores

Flowering Period: Fruiting body develops over weeks to months on the host wood

Robust biennial (occasionally annual) thistle (Asteraceae), 30-150 cm tall. Leaves are glossy dark green with distinctive white marbled veining (the 'milk' of legend), spiny-margined and deeply lobed. Large, solitary, purple-pink thistle-type flower heads are surrounded by spiny bracts, followed by shiny, mottled brown-black seeds - the part used.^[12]

Height: 30-150 cm

Habit: Robust biennial (occasionally annual) thistle

Leaves: Glossy dark green with white marbled veining, spiny-margined, deeply lobed

Flowers: Large, solitary, purple-pink thistle heads with spiny bracts

Stem: Erect, ridged

Root: Deep taproot

Fruit: Shiny, mottled brown-black seed (achene)

Flowering Period: June-August

Habitat

Grows as a wood-decay fungus on the stumps and trunks of deciduous trees (notably maple and other hardwoods) in East Asian forests; also widely cultivated commercially on hardwood logs or sawdust substrate.

Native to the Mediterranean region, now naturalised worldwide on disturbed, sunny ground - roadsides, waste places and dry pastures - and widely cultivated commercially for its seed.^[12]

Harvesting

Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then dried and processed into slices, powder or extract.

Parts: Mycelium, Whole Plant

Seed heads are harvested once fully dry (late summer), and the seeds (fruit) are threshed out.^[12]

Parts: Seed (fruit)

Season: Late summer

Traditional Uses

Reishi/lingzhi, the 'mushroom of immortality', is one of the most revered tonic fungi in traditional Chinese medicine, used for centuries to support vitality, calm the spirit, strengthen immunity and promote longevity; this traditional tonic reputation is now studied for immunomodulatory, anticancer-adjunct and metabolic effects.^{[1, 4]}

Milk thistle has a very long European folk-medicine tradition, documented since antiquity, as a liver tonic, and its seed extract, standardised to the flavonolignan complex silymarin, is one of the most extensively studied herbal hepatoprotectants. Modern research supports antioxidant, anti-inflammatory and liver-protective activity, with growing interest in metabolic/blood-sugar effects.^{[12, 13]}

Preparations

Standardised extract^{[1, 4]}

Extract standardised to polysaccharide (beta-glucan) or triterpene content, taken as capsules or powder; the form used in most modern studies.

Standardised extract (capsule/tablet)^{[12, 13]}

Standardised to silymarin content (typically 70-80%), the clinically studied commercial form.

References

REF-0821, REF-0822, REF-0823, REF-2039, REF-2040, REF-2041, REF-2042, REF-2043, REF-2044, REF-2045, REF-2046, REF-2047, REF-2048

REF-1896, REF-1897, REF-1898, REF-1899, REF-1900, REF-1901, REF-1902, REF-1903, REF-1904, REF-1905, REF-1906

Drug Class Interactions

Safety note^{[18, 19]}Caution

Drug Class: sedatives-cns-depressants

Mechanism: Reishi is traditionally used as a calming, sedative herb; taken with sedatives, sleeping tablets or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

Safety note^[16]Likely-safe

Drug Class: cyp3a4-substrates

Mechanism: Milk thistle (silymarin) was once thought to inhibit the CYP3A4 enzyme, but a controlled human study found no meaningful effect on a CYP3A4 test drug, so clinically important interactions with CYP3A4-metabolised medicines are unlikely at usual doses.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

Safety note^{[14, 17]}Caution

Drug Class: antidiabetics

Mechanism: Milk thistle (silymarin) reduced fasting blood glucose and HbA1c across randomized trials in type 2 diabetes; combined with diabetes medicines it may add to blood-sugar lowering, so monitor blood sugar.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

Lookalikes Review

Outcome: has-lookalikes

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Outcome: none-known

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Dangerous Lookalikes

Safety note^{[20, 21]}Fatal

Dangerous Plant: podostroma-cornu-damae

Confused Part: Wild-collected fruit bodies gathered as reishi/lingzhi for medicinal tea; the immature red, antler-like fruit bodies of poison fire coral can be taken for young reishi.

Confusion Context: Reishi (Ganoderma lingzhi / lucidum) is a hard, varnished bracket fungus collected and brewed as a health tonic. Poison fire coral (Podostroma cornu-damae), one of the few deadly-poisonous fungi, is documented to resemble Ganoderma lucidum in its immature stage. A peer-reviewed case report (Ahn et al., 2013, Yonsei Med J) describes two people who collected and boiled wild fungus as tea - one died of pancytopenia and multiple organ failure - and states that in its immature period poison fire coral resembles Ganoderma lucidum, 'well known as a health-food.' Its trichothecene mycotoxins (satratoxins) are frequently fatal. Because reishi is wild-collected for medicinal tea in East Asia, this is a genuinely lethal confusion.

Distinguishing Features: Colour and form: poison fire coral is bright blood-red to orange-red and grows as erect, often branched antler- or coral-like clubs rising from the ground or buried wood. True reishi is a flat kidney- or fan-shaped bracket (conk) with a hard, glossy, varnished red-brown to mahogany crust and a pale pored underside, growing on wood., Growth pattern: reishi forms a shelf/bracket with a distinct cap and often a lateral stalk; poison fire coral forms finger-like or antler-like red spikes with no cap., Underside: reishi has a white-to-brown pored underside that drops rusty-brown spores; poison fire coral has no pores at all.

Key Test: Look at the shape. Reishi is a hard, flat, varnished shelf/bracket with a pale pored underside, growing on wood. Any bright red, erect antler- or coral-like club with NO cap and NO pores is NOT reishi - it may be poison fire coral (Podostroma cornu-damae), which can kill. Never brew an unfamiliar red club or coral fungus; if unsure, do not use it and confirm with an expert mycologist.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Not documented

Dosage

Not documented

Standardised extract^{[12, 13]}

Clinical trials have most often used standardised extract providing 200-450 mg/day of silymarin, divided into 2-3 doses. Educational reference only, not a prescription.

References & Sources

Li, W., Zhou, Q., Lv, B., Li, N. et al (2024) 'Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer', Journal of Agricultural and Food Chemistry, 72(21), pp. 12072-12082. doi:10.1021/acs.jafc.3c08385 Preclinical
https://doi.org/10.1021/acs.jafc.3c08385
Cai, Q., Li, Y. and Pei, G (2017) 'Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response', Journal of Neuroinflammation, 14(1), pp. 63. doi:10.1186/s12974-017-0839-0 Preclinical
https://doi.org/10.1186/s12974-017-0839-0
Zheng, G., Zhao, Y., Li, Z., Hua, Y. et al (2023) 'Ganoderma lucidum spore powder and derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis', Theranostics, 13(4), pp. 1325-1341. doi:10.7150/thno.80250 Preclinical
https://doi.org/10.7150/thno.80250
Sohretoglu, D. and Huang, S (2018) 'Ganoderma lucidum Polysaccharides as An Anti-cancer Agent', Anti-Cancer Agents in Medicinal Chemistry, 18(5), pp. 667-674. doi:10.2174/1871520617666171113121246 Meta-analysis / review
https://doi.org/10.2174/1871520617666171113121246
Seweryn, E., Ziala, A. and Gamian, A (2021) 'Health-Promoting of Polysaccharides Extracted from Ganoderma lucidum', Nutrients, 13(8), pp. 2725. doi:10.3390/nu13082725 Meta-analysis / review
https://doi.org/10.3390/nu13082725
Liu, X., Yang, L., Li, G., Jiang, Y., Zhang, G. and Ling, J (2022) 'A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide', International Journal of Biological Macromolecules, 229, pp. 168-180. doi:10.1016/j.ijbiomac.2022.12.276 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2022.12.276
Zhu, M., Chang, Q., Wong, L.K., Chong, F.S. and Li, R.C (1999) 'Triterpene antioxidants from Ganoderma lucidum', Phytotherapy Research, 13(6), pp. 529-531. doi:10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x Preclinical
https://doi.org/10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x
Zeng, P., Chen, Y., Zhang, L. and Xing, M (2019) 'Ganoderma lucidum polysaccharide used for treating physical frailty in China', Progress in Molecular Biology and Translational Science, 163, pp. 179-219. doi:10.1016/bs.pmbts.2019.02.009 Meta-analysis / review
https://doi.org/10.1016/bs.pmbts.2019.02.009
Wu, P., Zhang, C., Yin, Y., Zhang, X., Li, Q., Yuan, L., Sun, Y., Zhou, S., Ying, S. and Wu, J (2024) 'Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review', Heliyon, 10(19), pp. e36987. doi:10.1016/j.heliyon.2024.e36987 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e36987
Xu, Z., Chen, X., Zhong, Z., Chen, L. and Wang, Y (2011) 'Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities', The American Journal of Chinese Medicine, 39(1), pp. 15-27. doi:10.1142/S0192415X11008610 Meta-analysis / review
https://doi.org/10.1142/S0192415X11008610
Geng, X., Zhong, D., Su, L., Lin, Z. and Yang, B (2019) 'Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases', Advances in Pharmacology, 87, pp. 257-276. doi:10.1016/bs.apha.2019.10.003 Meta-analysis / review
https://doi.org/10.1016/bs.apha.2019.10.003
Sliva, D (2004) 'Cellular and physiological effects of Ganoderma lucidum (Reishi)', Mini Reviews in Medicinal Chemistry, 4(8), pp. 873-879. doi:10.2174/1389557043403323 Meta-analysis / review
https://doi.org/10.2174/1389557043403323
Boh, B., Berovic, M., Zhang, J. and Zhi-Bin, L (2007) 'Ganoderma lucidum and its pharmaceutically active compounds', Biotechnology Annual Review, 13, pp. 265-301. doi:10.1016/S1387-2656(07)13010-6 Meta-analysis / review
https://doi.org/10.1016/S1387-2656(07)13010-6
Bao, X. et al (2001) 'Structural requirements for the immunological activities of polysaccharides from Ganoderma lucidum', 41(9), pp. 2603--2611. Traditional / reference
https://scholar.google.com/scholar?q=Structural%20requirements%20for%20the%20immunological%20activities%20of%20polysaccharides%20from%20Ganoderma%20lucidum
Jin, X. et al (2012) 'Ganoderma lucidum (Reishi mushroom) for cancer treatment'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Reishi%20mushroom%29%20for%20cancer%20treatment
Wachtel-Galor, S., Yuen, J., Buswell, J.A. and Benzie, I.F.F (2011) 'Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Lingzhi%20or%20Reishi%29%3A%20A%20Medicinal%20Mushroom
Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201
Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
Ahn, J.Y. and Seok, S.J. and Song, J.E. and Choi, J.H. and Han, S.H. and Choi, J.Y. and Kim, C.O. and Song, Y.G. and Kim, J.M (2013) 'Two cases of mushroom poisoning by Podostroma cornu-damae', Yonsei Medical Journal, 54(1), pp. 265-8. doi:10.3349/ymj.2013.54.1.265 Clinical study
https://doi.org/10.3349/ymj.2013.54.1.265
Choe, S. and In, S. and Jeon, Y. and Choi, H. and Kim, S (2018) 'Identification of trichothecene-type mycotoxins in toxic mushroom Podostroma cornu-damae and biological specimens from a fatal case by LC-QTOF/MS', Forensic Science International, 291, pp. 234-244. doi:10.1016/j.forsciint.2018.08.043 Clinical study
https://doi.org/10.1016/j.forsciint.2018.08.043

Abenavoli, L., Izzo, A.A., Milic, N., Cicala, C., Santini, A. and Capasso, R (2018) 'Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases', Phytotherapy Research, 32(11), pp. 2202-2213. doi:10.1002/ptr.6171 Meta-analysis / review
https://doi.org/10.1002/ptr.6171
Bahmani, M., Shirzad, H., Rafieian, S. and Rafieian-Kopaei, M (2015) 'Silybum marianum: Beyond Hepatoprotection', Journal of Evidence-Based Complementary & Alternative Medicine, 20(4), pp. 292-301. doi:10.1177/2156587215571116 Meta-analysis / review
https://doi.org/10.1177/2156587215571116
Wang, X., Zhang, Z. and Wu, S (2020) 'Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications', Journal of Agricultural and Food Chemistry, 68(42), pp. 11644-11664. doi:10.1021/acs.jafc.0c04791 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.0c04791
Marmouzi, I., Bouyahya, A., Ezzat, S.M., El Jemli, M. and Kharbach, M (2020) 'The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence', Journal of Ethnopharmacology, 265, pp. 113303. doi:10.1016/j.jep.2020.113303 Meta-analysis / review
https://doi.org/10.1016/j.jep.2020.113303
Greenlee, H., Abascal, K., Yarnell, E. and Ladas, E (2007) 'Clinical applications of Silybum marianum in oncology', Integrative Cancer Therapies, 6(2), pp. 158-165. doi:10.1177/1534735407301727 Meta-analysis / review
https://doi.org/10.1177/1534735407301727
Shaker, E., Mahmoud, H. and Mnaa, S (2009) 'Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage', Food and Chemical Toxicology, 48(3), pp. 803-806. doi:10.1016/j.fct.2009.12.011 Preclinical
https://doi.org/10.1016/j.fct.2009.12.011
Flora, K., Hahn, M., Rosen, H. and Benner, K (1998) 'Milk thistle (Silybum marianum) for the therapy of liver disease', American Journal of Gastroenterology, 93(2), pp. 139-143. doi:10.1111/j.1572-0241.1998.00139.x Meta-analysis / review
https://doi.org/10.1111/j.1572-0241.1998.00139.x
Csupor, D., Csorba, A. and Hohmann, J (2016) 'Recent advances in the analysis of flavonolignans of Silybum marianum', Journal of Pharmaceutical and Biomedical Analysis, 130, pp. 301-317. doi:10.1016/j.jpba.2016.05.034 Meta-analysis / review
https://doi.org/10.1016/j.jpba.2016.05.034
Ball, K.R. and Kowdley, K.V (2005) 'A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease', Journal of Clinical Gastroenterology, 39(6), pp. 520-528. doi:10.1097/01.mcg.0000165668.79530.a0 Meta-analysis / review
https://doi.org/10.1097/01.mcg.0000165668.79530.a0
Tajmohammadi, A., Razavi, B.M. and Hosseinzadeh, H (2018) 'Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review', Phytotherapy Research, 32(10), pp. 1933-1949. doi:10.1002/ptr.6153 Meta-analysis / review
https://doi.org/10.1002/ptr.6153
Ghahfarrokhi, S.H., Heidari-Soureshjani, S., Sherwin, C.M.T. and Azadegan-Dehkordi, Z (2024) 'Efficacy and Mechanisms of Silybum marianum, Silymarin, and Silibinin on Rheumatoid Arthritis and Osteoarthritis Symptoms: A Systematic Review', Current Rheumatology Reviews, 20(4), pp. 414-425. doi:10.2174/0115733971266397231122080247 Meta-analysis / review
https://doi.org/10.2174/0115733971266397231122080247
Soleimani, V., Delghandi, P.S., Moallem, S.A. and Karimi, G (2019) 'Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review', Phytotherapy Research. doi:10.1002/ptr.6361 Randomized trial
https://doi.org/10.1002/ptr.6361
Fallah, M., Davoodvandi, A., Nikmanzar, S., Aghili, S., Mirazimi, S.M.A., Aschner, M., Rashidian, A., Hamblin, M.R., Chamanara, M., Naghsh, N. and Mirzaei, H (2021) 'Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer', Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2021.112024 Preclinical
https://doi.org/10.1016/j.biopha.2021.112024
Voroneanu, L., Nistor, I., Dumea, R., Apetrii, M. and Covic, A (2016) 'Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Journal of Diabetes Research. doi:10.1155/2016/5147468 Meta-analysis / review
https://doi.org/10.1155/2016/5147468
Zhou, J., Chen, Y., Yu, J., Li, T., Lu, Z., Chen, Y., Zhang, X. and Ye, F (2021) 'The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials', Medicine (Baltimore), 100(12). doi:10.1097/MD.0000000000024884 Meta-analysis / review
https://doi.org/10.1097/MD.0000000000024884
Fuhr, U., Beckmann-Knopp, S., Jetter, A., Lueck, H. and Mengs, U (2007) 'The effect of silymarin on oral nifedipine pharmacokinetics', Planta Medica, 73(14), pp. 1429-1435. doi:10.1055/s-2007-990256 Randomized trial
https://doi.org/10.1055/s-2007-990256
Hadi, A., Pourmasoumi, M., Mohammadi, H., Symonds, M. and Miraghajani, M (2018) 'The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials', Complementary Therapies in Medicine, 41, pp. 311-319. doi:10.1016/j.ctim.2018.08.010 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2018.08.010

Lingzhi monograph Milk Thistle monograph Compare other plants

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.